Stock CLGN COLLPLANT BIOTECHNOLOGIES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus CollPlant Biotechnologies Ltd.

Equities

CLGN

IL0004960188

Delayed Nasdaq
Other stock markets
 11:16:34 2024-04-29 am EDT 		5-day change 1st Jan Change
5.59 USD -5.09% Intraday chart for CollPlant Biotechnologies Ltd. +6.27% -12.52%
Apr. 04 CollPlant Biotechnologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 02 CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants CI

Evolution of the average Target Price on CollPlant Biotechnologies Ltd.

Price target over the last 5 years

History of analyst recommendation changes

2692a.pDcGZcd0Ad19AXgiQ7IwYQKhxfEg-PtAM8VU9rLpfWg.8HNVIbMGUewrSz11NMddUlTngq5FoYMadqg1peCqLybIWVwQjzAxqBBlMQ~02ea17e1ff6f39d6ca3be12e285a2aeb

Analyst Recommendations on CollPlant Biotechnologies Ltd.

HC Wainwright Adjusts Price Target on CollPlant Holdings to $11 From $26, Maintains Buy Rating MT
COLLPLANT BIOTECHNOLOGIES : HC Wainwright Adjusts Price Target on CollPlant Holdings to $26 From $13, Keeps Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
5.89 USD
Average target price
11 USD
Spread / Average Target
+86.76%
High Price Target
11 USD
Spread / Highest target
+86.76%
Low Price Target
11 USD
Spread / Lowest Target
+86.76%

Consensus detail

Consensus revision (last 18 months)

Analysts covering CollPlant Biotechnologies Ltd.

HC Wainwright

Ratings for CollPlant Biotechnologies Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CLGN Stock
  4. Consensus CollPlant Biotechnologies Ltd.